AtriCure, Inc. Announces Preliminary Results For Fourth Quarter And Full Year 2013 And Issues 2014 Guidance

AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced preliminary financial results for fourth quarter and full year 2013 and issued 2014 financial guidance.

Preliminary revenue for the fourth quarter of 2013 is expected to be approximately $21.9 million, reflecting growth of approximately 19% over the fourth quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.